Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters

Published:2015-05 Issue: Volume:72 Page:37-43
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chun So-Young,Kwon Yun-Suk,Nam Kyung-Soo,Kim Soyoung

Funder

National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference31 articles.

1. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc. Natl. Acad. Sci. U. S. A.,2003

2. Unravelling cancer stem cell potential;Beck;Nat. Rev. Cancer,2013

3. ABC transporters, drug resistance, and cancer stem cells;Dean;J. Mammary Gland Biol. Neoplasia,2009

4. Tumour stem cells and drug resistance;Dean;Nat. Rev. Cancer,2005

5. ABC transporters: from microorganisms to man;Higgins;Annu. Rev. Cell Biol.,1992

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro;International Journal of Molecular Sciences;2024-03-06

2. Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer;European Journal of Medicinal Chemistry;2024-02

3. Design of balanced dual-target inhibitors of EGFR and microtubule;Bioorganic Chemistry;2024-02

4. Co-delivery of lapatinib and 5-fluorouracil transfersomes using transpapillary iontophoresis for breast cancer therapy;International Journal of Pharmaceutics;2024-01

5. Overexpression of ABCC1 and ABCG2 Confers Resistance to Talazoparib, a Poly (ADP-Ribose) Polymerase Inhibitor;Drug Resistance Updates;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3